198 related articles for article (PubMed ID: 15232663)
1. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism.
Araki K; Yasui-Furukori N; Fukasawa T; Aoshima T; Suzuki A; Inoue Y; Tateishi T; Otani K
Eur J Clin Pharmacol; 2004 Aug; 60(6):427-30. PubMed ID: 15232663
[TBL] [Abstract][Full Text] [Related]
2. Induction of the metabolism of etizolam by carbamazepine in humans.
Kondo S; Fukasawa T; Yasui-Furukori N; Aoshima T; Suzuki A; Inoue Y; Tateishi T; Otani K
Eur J Clin Pharmacol; 2005 May; 61(3):185-8. PubMed ID: 15776275
[TBL] [Abstract][Full Text] [Related]
3. No effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of estazolam.
Otsuji Y; Okuyama N; Aoshima T; Fukasawa T; Kato K; Gerstenberg G; Miura M; Ohkubo T; Sugawara K; Otani K
Ther Drug Monit; 2002 Jun; 24(3):375-8. PubMed ID: 12021628
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity.
Fukasawa T; Yasui-Furukori N; Suzuki A; Inoue Y; Tateishi T; Otani K
Eur J Clin Pharmacol; 2005 Dec; 61(11):791-5. PubMed ID: 16261363
[TBL] [Abstract][Full Text] [Related]
5. The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers.
Oda M; Kotegawa T; Tsutsumi K; Ohtani Y; Kuwatani K; Nakano S
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):615-9. PubMed ID: 14517708
[TBL] [Abstract][Full Text] [Related]
6. Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug.
Kato K; Yasui-Furukori N; Fukasawa T; Aoshima T; Suzuki A; Kanno M; Otani K
Ther Drug Monit; 2003 Aug; 25(4):473-7. PubMed ID: 12883232
[TBL] [Abstract][Full Text] [Related]
7. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of a single oral dose of brotizolam.
Osanai T; Ohkubo T; Yasui N; Kondo T; Kaneko S
Br J Clin Pharmacol; 2004 Nov; 58(5):476-81. PubMed ID: 15521894
[TBL] [Abstract][Full Text] [Related]
8. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
[TBL] [Abstract][Full Text] [Related]
9. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam.
Yasui N; Kondo T; Otani K; Furukori H; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole increases plasma concentrations of quinidine.
Kaukonen KM; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
[TBL] [Abstract][Full Text] [Related]
11. The effect of the antimycotic itraconazole on the pharmacokinetics and pharmacodynamics of diazepam.
Ahonen J; Olkkola KT; Neuvonen PJ
Fundam Clin Pharmacol; 1996; 10(3):314-8. PubMed ID: 8836707
[TBL] [Abstract][Full Text] [Related]
12. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
Varis T; Kivistö KT; Backman JT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole.
Varis T; Kaukonen KM; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792
[TBL] [Abstract][Full Text] [Related]
14. Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
Kivistö KT; Wang JS; Backman JT; Nyman L; Taavitsainen P; Anttila M; Neuvonen PJ
Eur J Clin Pharmacol; 2001 Apr; 57(1):37-42. PubMed ID: 11372588
[TBL] [Abstract][Full Text] [Related]
15. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
[TBL] [Abstract][Full Text] [Related]
16. Notable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19.
Yamamoto T; Furihata K; Hisaka A; Moritoyo T; Ogoe K; Kusayama S; Motohashi K; Mori A; Iwatsubo T; Suzuki H
J Clin Pharmacol; 2017 Nov; 57(11):1491-1499. PubMed ID: 28679023
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
Neuvonen PJ; Kantola T; Kivistö KT
Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
Karonen T; Laitila J; Niemi M; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2012 May; 68(5):681-8. PubMed ID: 22108774
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.
Park JY; Shon JH; Kim KA; Jung HJ; Shim JC; Yoon YR; Cha IJ; Shin JG
J Clin Psychopharmacol; 2006 Apr; 26(2):135-42. PubMed ID: 16633141
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
Niemi M; Tornio A; Pasanen MK; Fredrikson H; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]